Your Custom Text Here
Intellectual property emerging from our laboratory includes:
Methods for Selective Inhibition of Pluripotent Stem CellsPCT/US15/12218. Click here for more information.Cardiomyocyte specific biological markers and uses thereofUS provisional application # 62/184,397.
Licensing opportunities for these technologies are available. Contact Dr. Gundry or Kalpa Vithalani PhD, our Licensing Manager in the the Office of Technology Development.